You're contacting media contact of this press release

Title: K-38 Consulting Expands Fractional CFO Services for Biotech Startups, Addressing a Critical Financial Leadership Gap in Life Sciences

Raleigh, North Carolina, United States, 15th Jun 2026-- K-38 Consulting, a leading provider of outsourced CFO and accounting services for startups and mid-size businesses, today announced the formal expansion of its specialized Biotech CFO Services division. The initiative is designed to close the growing financial leadership gap in life sciences, where pre-revenue companies routinely burn through capital without the strategic financial infrastructure needed to survive and scale.With R&D spending in the biotech sector projected to grow by 11% year-over-year and 46% of biotech companies anticipating greater difficulty securing funding over the next 18 months, the demand for expert financial guidance has never been more urgent. K-38 Consulting is responding directly to that challenge, offering fractional CFO engagements that deliver the financial strategy and oversight of a seasoned executive at a fraction of the cost. More information can be found at https://www.k38consulting.com/startup-industry-expertise/healthcare-cfo-services. The Biotech Financial Crisis No One Is Talking AboutThe financial realities facing biotech startups are unlike those in any other industry. Companies in this sector routinely spend years in pre-revenue development, burning through capital on clinical trials, lab infrastructure, and regulatory compliance before generating a single dollar in commercial revenue. R&D costs alone account for roughly 25% of a typical biotech startup's total spend rate. A basic ELISA test through a Contract Research Organization can run over $25,000, while patent filings range from $10,000 to $15,000 domestically and can exceed $50,000 internationally.Despite this financial complexity, an alarming 62% of public biotech companies see their CFO role fi...

This press release is issued by King Newswire